Michael Ordon

Adjunct Scientist (Full Status)

ICES Affiliation

ICES Western
Kidney, Dialysis & Transplantation Research Program

Phone
416-867-3705

Biography

Contact Michael Ordon

Education

FRCSC, Urology, Royal College of Physicians and Surgeons of Canada
MD, University of Toronto
MSc, Clinical Epidemiology and Health Care Research, Institute for Health Policy, Management and Evaluation, University of Toronto
BA, Psychology, University of Western Ontario

Research Focus

Kidney and urinary tract disorders
Transplantation
Outcomes research

Other Affiliations

Assistant Professor, Department of Surgery, University of Toronto
Urologist, St. Michael's Hospital
Associate Scientist, Li Ka Shing Knowledge Institute, St. Michael's Hospital

Recent ICES Grants

Filling knowledge gaps for the success of Ontario Renal Plan 3
Principal investigator: Beaucage MB, Chanchlani R, Clark EG, Clemens KK, Coghlan C, Dixon SN, Field B, ; Harel Z, Jain AK, Molnar A, Silver S, Sood MM, Weir MA, Zappitelli M
Co-investigators: Al-Jaishi A, Bhasin AA, Blake PG, Garg A, Harvey-Rioux L, Kitchlu A, Knoll G, Kurdyak PA, Muanda F, Nash DM, Naylor K, Nesrallah G, Oliver MJ, Ordon M, Paterson M, Perl J, Roshanov P, Wald R, Walsh MW, Welk BK, Young A Canadian Institutes of Health Research, Project Grant
2019-2020; $100,000
The impact of early vs. delayed intervention for acutely symptomatic renal calculi: a population-based study

Principal investigator: Ordon M
Co-investigator: Welk B
American Urology Association, Young Investigator Research Grant
2018-2020; $30,000 USD
The impact of Choosing Wisely urology campaign on medical care in the United States and Canada

Principal investigators: Ordon M, Welk B
Co-investigator: Garg A
American Urology Association, Data Services Grant
2015-2019; $24,192

Recent ICES Publications

10/29/2022

5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort

Dekalo S, McArthur E, Campbell J, Ordon M, Power N, Welk B. Urol Oncol. 2022; Oct 29 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.urolonc.2022.09.004

1/29/2021

Do 5 alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?

Welk B, Reid J, Ordon M, Campbell J, Dixon S. Can Urol Assoc J. 2021; 15(6):214-6. Epub 2021 Jan 29. DOI: https://doi.org/10.5489/cuaj.7135

6/1/2020

A propensity score-weighted comparison of outcomes between living and standard criteria deceased donor kidney transplant recipients

Yohanna S, Naylor KL, McArthur E, Lam NN, Austin PC, Habbous S, McCallum MK, Ordon M, Knoll GA, Kim JS, Garg AX. Transplantation. 2020; 104(11):e317-e27. Epub 2020 Jun 1. DOI: https://doi.org/10.1097/TP.0000000000003337

See more ICES Publications